Laurion Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-100,000
Closed -$6.09M 500
2019
Q4
$6.09M Buy
+100,000
New +$6.09M 0.05% 50
2018
Q4
Sell
-172,725
Closed -$7.66M 747
2018
Q3
$7.66M Buy
+172,725
New +$7.66M 0.07% 83
2017
Q4
Sell
-67,636
Closed -$1.21M 1134
2017
Q3
$1.21M Buy
+67,636
New +$1.21M 0.01% 490
2017
Q1
Sell
-26,000
Closed -$527K 871
2016
Q4
$527K Buy
+26,000
New +$527K 0.01% 424